Registry for valve replacement in bicuspid aortic stenosis patients
Part of Genetic & congenital, Heart & circulation clinical trials.
This registry collects information about adults with severe narrowing of the aortic valve caused by a bicuspid (two-leaflet) valve shape, especially if symptoms are present. It may help doctors better understand who benefits from a catheter-based valve replacement (TAVR).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have severe aortic valve narrowing (aortic stenosis) and a bicuspid valve shape
- Have symptoms such as shortness of breath with activity (NYHA 2 or higher), fainting (syncope), and/or chest pain (angina)
- Your care team (the Heart Team) must believe you need TAVR (a catheter-based valve replacement)
- Your condition is not only pure aortic valve leak (pure regurgitation)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for severe aortic stenosis in people with a bicuspid aortic valve: transcatheter aortic valve replacement (TAVR, a less invasive procedure) and surgical aortic valve replacement (SAVR, open-heart surgery). The goal is to see which approach works better for this specific condition.
This study is a registry that collects health information from adults with bicuspid aortic valve disease. It may help doctors better understand outcomes and guide future care for patients and families affected by this condition.
This trial tests a special heart valve (ACURATE neo2) in people with severe aortic stenosis who also have a bicuspid aortic valve, a common birth difference. The goal is to see if the valve is safe and works well for these patients.
This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.
This registry is for people with severe, symptomatic aortic valve narrowing who are planning a TAVI procedure (a less invasive valve replacement). It aims to better track and improve how patients do after the valve is replaced, based on how the procedure is planned and performed.
This study tracks patients with severe aortic stenosis who receive the Myval transcatheter heart valve during TAVR (a less-invasive valve replacement). It aims to understand how well the valve works over time.
Hear when a new Bicuspid Aortic Valve trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.